| 摘要 |
<p>A new group of compounds having muscarinic activity is disclosed. The use of the compounds and pharmaceutically acceptable salts thereof to treat glaucoma, myopia, psychosis and various other conditions involving muscarinic receptors is also disclosed.</p> |
